Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral T-cell lymphoma Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Chidamide
1.2.3 Selinexor
1.2.4 Other
1.3 Market by Application
1.3.1 Global Peripheral T-cell lymphoma Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peripheral T-cell lymphoma Therapy Market Perspective (2018-2033)
2.2 Global Peripheral T-cell lymphoma Therapy Growth Trends by Region
2.2.1 Peripheral T-cell lymphoma Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Peripheral T-cell lymphoma Therapy Historic Market Size by Region (2018-2023)
2.2.3 Peripheral T-cell lymphoma Therapy Forecasted Market Size by Region (2024-2033)
2.3 Peripheral T-cell lymphoma Therapy Market Dynamics
2.3.1 Peripheral T-cell lymphoma Therapy Industry Trends
2.3.2 Peripheral T-cell lymphoma Therapy Market Drivers
2.3.3 Peripheral T-cell lymphoma Therapy Market Challenges
2.3.4 Peripheral T-cell lymphoma Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Peripheral T-cell lymphoma Therapy by Players
3.1.1 Global Peripheral T-cell lymphoma Therapy Revenue by Players (2018-2023)
3.1.2 Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Peripheral T-cell lymphoma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Peripheral T-cell lymphoma Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Peripheral T-cell lymphoma Therapy Market Concentration Ratio
3.4.1 Global Peripheral T-cell lymphoma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral T-cell lymphoma Therapy Revenue in 2022
3.5 Global Key Players of Peripheral T-cell lymphoma Therapy Head office and Area Served
3.6 Global Key Players of Peripheral T-cell lymphoma Therapy, Product and Application
3.7 Global Key Players of Peripheral T-cell lymphoma Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral T-cell lymphoma Therapy Breakdown Data by Type
4.1 Global Peripheral T-cell lymphoma Therapy Historic Market Size by Type (2018-2023)
4.2 Global Peripheral T-cell lymphoma Therapy Forecasted Market Size by Type (2024-2033)
5 Peripheral T-cell lymphoma Therapy Breakdown Data by Application
5.1 Global Peripheral T-cell lymphoma Therapy Historic Market Size by Application (2018-2023)
5.2 Global Peripheral T-cell lymphoma Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Peripheral T-cell lymphoma Therapy Market Size (2018-2033)
6.2 North America Peripheral T-cell lymphoma Therapy Market Size by Type
6.2.1 North America Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023)
6.2.2 North America Peripheral T-cell lymphoma Therapy Market Size by Type (2024-2033)
6.2.3 North America Peripheral T-cell lymphoma Therapy Market Share by Type (2018-2033)
6.3 North America Peripheral T-cell lymphoma Therapy Market Size by Application
6.3.1 North America Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023)
6.3.2 North America Peripheral T-cell lymphoma Therapy Market Size by Application (2024-2033)
6.3.3 North America Peripheral T-cell lymphoma Therapy Market Share by Application (2018-2033)
6.4 North America Peripheral T-cell lymphoma Therapy Market Size by Country
6.4.1 North America Peripheral T-cell lymphoma Therapy Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Peripheral T-cell lymphoma Therapy Market Size by Country (2018-2023)
6.4.3 North America Peripheral T-cell lymphoma Therapy Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Peripheral T-cell lymphoma Therapy Market Size (2018-2033)
7.2 Europe Peripheral T-cell lymphoma Therapy Market Size by Type
7.2.1 Europe Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023)
7.2.2 Europe Peripheral T-cell lymphoma Therapy Market Size by Type (2024-2033)
7.2.3 Europe Peripheral T-cell lymphoma Therapy Market Share by Type (2018-2033)
7.3 Europe Peripheral T-cell lymphoma Therapy Market Size by Application
7.3.1 Europe Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023)
7.3.2 Europe Peripheral T-cell lymphoma Therapy Market Size by Application (2024-2033)
7.3.3 Europe Peripheral T-cell lymphoma Therapy Market Share by Application (2018-2033)
7.4 Europe Peripheral T-cell lymphoma Therapy Market Size by Country
7.4.1 Europe Peripheral T-cell lymphoma Therapy Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Peripheral T-cell lymphoma Therapy Market Size by Country (2018-2023)
7.4.3 Europe Peripheral T-cell lymphoma Therapy Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Peripheral T-cell lymphoma Therapy Market Size (2018-2033)
8.2 China Peripheral T-cell lymphoma Therapy Market Size by Type
8.2.1 China Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023)
8.2.2 China Peripheral T-cell lymphoma Therapy Market Size by Type (2024-2033)
8.2.3 China Peripheral T-cell lymphoma Therapy Market Share by Type (2018-2033)
8.3 China Peripheral T-cell lymphoma Therapy Market Size by Application
8.3.1 China Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023)
8.3.2 China Peripheral T-cell lymphoma Therapy Market Size by Application (2024-2033)
8.3.3 China Peripheral T-cell lymphoma Therapy Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Peripheral T-cell lymphoma Therapy Market Size (2018-2033)
9.2 Asia Peripheral T-cell lymphoma Therapy Market Size by Type
9.2.1 Asia Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023)
9.2.2 Asia Peripheral T-cell lymphoma Therapy Market Size by Type (2024-2033)
9.2.3 Asia Peripheral T-cell lymphoma Therapy Market Share by Type (2018-2033)
9.3 Asia Peripheral T-cell lymphoma Therapy Market Size by Application
9.3.1 Asia Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023)
9.3.2 Asia Peripheral T-cell lymphoma Therapy Market Size by Application (2024-2033)
9.3.3 Asia Peripheral T-cell lymphoma Therapy Market Share by Application (2018-2033)
9.4 Asia Peripheral T-cell lymphoma Therapy Market Size by Region
9.4.1 Asia Peripheral T-cell lymphoma Therapy Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Peripheral T-cell lymphoma Therapy Market Size by Region (2018-2023)
9.4.3 Asia Peripheral T-cell lymphoma Therapy Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Antengene
11.1.1 Antengene Company Details
11.1.2 Antengene Business Overview
11.1.3 Antengene Peripheral T-cell lymphoma Therapy Introduction
11.1.4 Antengene Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023)
11.1.5 Antengene Recent Developments
11.2 Genor BioPharma Co., Ltd.
11.2.1 Genor BioPharma Co., Ltd. Company Details
11.2.2 Genor BioPharma Co., Ltd. Business Overview
11.2.3 Genor BioPharma Co., Ltd. Peripheral T-cell lymphoma Therapy Introduction
11.2.4 Genor BioPharma Co., Ltd. Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023)
11.2.5 Genor BioPharma Co., Ltd. Recent Developments
11.3 Hospira (Pfizer Inc.)
11.3.1 Hospira (Pfizer Inc.) Company Details
11.3.2 Hospira (Pfizer Inc.) Business Overview
11.3.3 Hospira (Pfizer Inc.) Peripheral T-cell lymphoma Therapy Introduction
11.3.4 Hospira (Pfizer Inc.) Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023)
11.3.5 Hospira (Pfizer Inc.) Recent Developments
11.4 Dizal Pharma
11.4.1 Dizal Pharma Company Details
11.4.2 Dizal Pharma Business Overview
11.4.3 Dizal Pharma Peripheral T-cell lymphoma Therapy Introduction
11.4.4 Dizal Pharma Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023)
11.4.5 Dizal Pharma Recent Developments
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Company Details
11.5.2 Bristol-Myers Squibb Company Business Overview
11.5.3 Bristol-Myers Squibb Company Peripheral T-cell lymphoma Therapy Introduction
11.5.4 Bristol-Myers Squibb Company Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023)
11.5.5 Bristol-Myers Squibb Company Recent Developments
11.6 Sigma-Tau Pharmaceuticals, Inc.
11.6.1 Sigma-Tau Pharmaceuticals, Inc. Company Details
11.6.2 Sigma-Tau Pharmaceuticals, Inc. Business Overview
11.6.3 Sigma-Tau Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Introduction
11.6.4 Sigma-Tau Pharmaceuticals, Inc. Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023)
11.6.5 Sigma-Tau Pharmaceuticals, Inc. Recent Developments
11.7 Pacira Pharmaceuticals, Inc.
11.7.1 Pacira Pharmaceuticals, Inc. Company Details
11.7.2 Pacira Pharmaceuticals, Inc. Business Overview
11.7.3 Pacira Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Introduction
11.7.4 Pacira Pharmaceuticals, Inc. Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023)
11.7.5 Pacira Pharmaceuticals, Inc. Recent Developments
11.8 Spectrum Pharmaceuticals, Inc.
11.8.1 Spectrum Pharmaceuticals, Inc. Company Details
11.8.2 Spectrum Pharmaceuticals, Inc. Business Overview
11.8.3 Spectrum Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Introduction
11.8.4 Spectrum Pharmaceuticals, Inc. Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023)
11.8.5 Spectrum Pharmaceuticals, Inc. Recent Developments
11.9 Celgene Corporation
11.9.1 Celgene Corporation Company Details
11.9.2 Celgene Corporation Business Overview
11.9.3 Celgene Corporation Peripheral T-cell lymphoma Therapy Introduction
11.9.4 Celgene Corporation Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023)
11.9.5 Celgene Corporation Recent Developments
11.10 Eisai Co., Ltd.
11.10.1 Eisai Co., Ltd. Company Details
11.10.2 Eisai Co., Ltd. Business Overview
11.10.3 Eisai Co., Ltd. Peripheral T-cell lymphoma Therapy Introduction
11.10.4 Eisai Co., Ltd. Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023)
11.10.5 Eisai Co., Ltd. Recent Developments
11.11 Leadiant Biosciences
11.11.1 Leadiant Biosciences Company Details
11.11.2 Leadiant Biosciences Business Overview
11.11.3 Leadiant Biosciences Peripheral T-cell lymphoma Therapy Introduction
11.11.4 Leadiant Biosciences Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023)
11.11.5 Leadiant Biosciences Recent Developments
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Peripheral T-cell lymphoma Therapy Introduction
11.12.4 Merck Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023)
11.12.5 Merck Recent Developments
11.13 Genmab AS
11.13.1 Genmab AS Company Details
11.13.2 Genmab AS Business Overview
11.13.3 Genmab AS Peripheral T-cell lymphoma Therapy Introduction
11.13.4 Genmab AS Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023)
11.13.5 Genmab AS Recent Developments
11.14 HUYABIO International
11.14.1 HUYABIO International Company Details
11.14.2 HUYABIO International Business Overview
11.14.3 HUYABIO International Peripheral T-cell lymphoma Therapy Introduction
11.14.4 HUYABIO International Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023)
11.14.5 HUYABIO International Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Peripheral T-cell lymphoma Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Chidamide
Table 3. Key Players of Selinexor
Table 4. Key Players of Other
Table 5. Global Peripheral T-cell lymphoma Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Peripheral T-cell lymphoma Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Peripheral T-cell lymphoma Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Peripheral T-cell lymphoma Therapy Market Share by Region (2018-2023)
Table 9. Global Peripheral T-cell lymphoma Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Peripheral T-cell lymphoma Therapy Market Share by Region (2024-2033)
Table 11. Peripheral T-cell lymphoma Therapy Market Trends
Table 12. Peripheral T-cell lymphoma Therapy Market Drivers
Table 13. Peripheral T-cell lymphoma Therapy Market Challenges
Table 14. Peripheral T-cell lymphoma Therapy Market Restraints
Table 15. Global Peripheral T-cell lymphoma Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Peripheral T-cell lymphoma Therapy Revenue Share by Players (2018-2023)
Table 17. Global Top Peripheral T-cell lymphoma Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral T-cell lymphoma Therapy as of 2022)
Table 18. Global Peripheral T-cell lymphoma Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Peripheral T-cell lymphoma Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Peripheral T-cell lymphoma Therapy, Headquarters and Area Served
Table 21. Global Key Players of Peripheral T-cell lymphoma Therapy, Product and Application
Table 22. Global Key Players of Peripheral T-cell lymphoma Therapy, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Type (2018-2023)
Table 26. Global Peripheral T-cell lymphoma Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Type (2024-2033)
Table 28. Global Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Peripheral T-cell lymphoma Therapy Revenue Share by Application (2018-2023)
Table 30. Global Peripheral T-cell lymphoma Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Peripheral T-cell lymphoma Therapy Revenue Share by Application (2024-2033)
Table 32. North America Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Peripheral T-cell lymphoma Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Peripheral T-cell lymphoma Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Peripheral T-cell lymphoma Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Peripheral T-cell lymphoma Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Peripheral T-cell lymphoma Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Peripheral T-cell lymphoma Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Peripheral T-cell lymphoma Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Peripheral T-cell lymphoma Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Peripheral T-cell lymphoma Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Peripheral T-cell lymphoma Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Peripheral T-cell lymphoma Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Peripheral T-cell lymphoma Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Peripheral T-cell lymphoma Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Peripheral T-cell lymphoma Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Peripheral T-cell lymphoma Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Peripheral T-cell lymphoma Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Peripheral T-cell lymphoma Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 64. Antengene Company Details
Table 65. Antengene Business Overview
Table 66. Antengene Peripheral T-cell lymphoma Therapy Product
Table 67. Antengene Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023) & (US$ Million)
Table 68. Antengene Recent Developments
Table 69. Genor BioPharma Co., Ltd. Company Details
Table 70. Genor BioPharma Co., Ltd. Business Overview
Table 71. Genor BioPharma Co., Ltd. Peripheral T-cell lymphoma Therapy Product
Table 72. Genor BioPharma Co., Ltd. Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023) & (US$ Million)
Table 73. Genor BioPharma Co., Ltd. Recent Developments
Table 74. Hospira (Pfizer Inc.) Company Details
Table 75. Hospira (Pfizer Inc.) Business Overview
Table 76. Hospira (Pfizer Inc.) Peripheral T-cell lymphoma Therapy Product
Table 77. Hospira (Pfizer Inc.) Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023) & (US$ Million)
Table 78. Hospira (Pfizer Inc.) Recent Developments
Table 79. Dizal Pharma Company Details
Table 80. Dizal Pharma Business Overview
Table 81. Dizal Pharma Peripheral T-cell lymphoma Therapy Product
Table 82. Dizal Pharma Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023) & (US$ Million)
Table 83. Dizal Pharma Recent Developments
Table 84. Bristol-Myers Squibb Company Company Details
Table 85. Bristol-Myers Squibb Company Business Overview
Table 86. Bristol-Myers Squibb Company Peripheral T-cell lymphoma Therapy Product
Table 87. Bristol-Myers Squibb Company Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023) & (US$ Million)
Table 88. Bristol-Myers Squibb Company Recent Developments
Table 89. Sigma-Tau Pharmaceuticals, Inc. Company Details
Table 90. Sigma-Tau Pharmaceuticals, Inc. Business Overview
Table 91. Sigma-Tau Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product
Table 92. Sigma-Tau Pharmaceuticals, Inc. Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023) & (US$ Million)
Table 93. Sigma-Tau Pharmaceuticals, Inc. Recent Developments
Table 94. Pacira Pharmaceuticals, Inc. Company Details
Table 95. Pacira Pharmaceuticals, Inc. Business Overview
Table 96. Pacira Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product
Table 97. Pacira Pharmaceuticals, Inc. Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023) & (US$ Million)
Table 98. Pacira Pharmaceuticals, Inc. Recent Developments
Table 99. Spectrum Pharmaceuticals, Inc. Company Details
Table 100. Spectrum Pharmaceuticals, Inc. Business Overview
Table 101. Spectrum Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product
Table 102. Spectrum Pharmaceuticals, Inc. Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023) & (US$ Million)
Table 103. Spectrum Pharmaceuticals, Inc. Recent Developments
Table 104. Celgene Corporation Company Details
Table 105. Celgene Corporation Business Overview
Table 106. Celgene Corporation Peripheral T-cell lymphoma Therapy Product
Table 107. Celgene Corporation Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023) & (US$ Million)
Table 108. Celgene Corporation Recent Developments
Table 109. Eisai Co., Ltd. Company Details
Table 110. Eisai Co., Ltd. Business Overview
Table 111. Eisai Co., Ltd. Peripheral T-cell lymphoma Therapy Product
Table 112. Eisai Co., Ltd. Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023) & (US$ Million)
Table 113. Eisai Co., Ltd. Recent Developments
Table 114. Leadiant Biosciences Company Details
Table 115. Leadiant Biosciences Business Overview
Table 116. Leadiant Biosciences Peripheral T-cell lymphoma Therapy Product
Table 117. Leadiant Biosciences Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023) & (US$ Million)
Table 118. Leadiant Biosciences Recent Developments
Table 119. Merck Company Details
Table 120. Merck Business Overview
Table 121. Merck Peripheral T-cell lymphoma Therapy Product
Table 122. Merck Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023) & (US$ Million)
Table 123. Merck Recent Developments
Table 124. Genmab AS Company Details
Table 125. Genmab AS Business Overview
Table 126. Genmab AS Peripheral T-cell lymphoma Therapy Product
Table 127. Genmab AS Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023) & (US$ Million)
Table 128. Genmab AS Recent Developments
Table 129. HUYABIO International Company Details
Table 130. HUYABIO International Business Overview
Table 131. HUYABIO International Peripheral T-cell lymphoma Therapy Product
Table 132. HUYABIO International Revenue in Peripheral T-cell lymphoma Therapy Business (2018-2023) & (US$ Million)
Table 133. HUYABIO International Recent Developments
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peripheral T-cell lymphoma Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Peripheral T-cell lymphoma Therapy Market Share by Type: 2022 VS 2033
Figure 3. Chidamide Features
Figure 4. Selinexor Features
Figure 5. Other Features
Figure 6. Global Peripheral T-cell lymphoma Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Peripheral T-cell lymphoma Therapy Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Peripheral T-cell lymphoma Therapy Report Years Considered
Figure 11. Global Peripheral T-cell lymphoma Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Peripheral T-cell lymphoma Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Peripheral T-cell lymphoma Therapy Market Share by Region: 2022 VS 2033
Figure 14. Global Peripheral T-cell lymphoma Therapy Market Share by Players in 2022
Figure 15. Global Top Peripheral T-cell lymphoma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral T-cell lymphoma Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Peripheral T-cell lymphoma Therapy Revenue in 2022
Figure 17. North America Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Peripheral T-cell lymphoma Therapy Market Share by Type (2018-2033)
Figure 19. North America Peripheral T-cell lymphoma Therapy Market Share by Application (2018-2033)
Figure 20. North America Peripheral T-cell lymphoma Therapy Market Share by Country (2018-2033)
Figure 21. United States Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Peripheral T-cell lymphoma Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Peripheral T-cell lymphoma Therapy Market Share by Type (2018-2033)
Figure 25. Europe Peripheral T-cell lymphoma Therapy Market Share by Application (2018-2033)
Figure 26. Europe Peripheral T-cell lymphoma Therapy Market Share by Country (2018-2033)
Figure 27. Germany Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Peripheral T-cell lymphoma Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Peripheral T-cell lymphoma Therapy Market Share by Type (2018-2033)
Figure 35. China Peripheral T-cell lymphoma Therapy Market Share by Application (2018-2033)
Figure 36. Asia Peripheral T-cell lymphoma Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Peripheral T-cell lymphoma Therapy Market Share by Type (2018-2033)
Figure 38. Asia Peripheral T-cell lymphoma Therapy Market Share by Application (2018-2033)
Figure 39. Asia Peripheral T-cell lymphoma Therapy Market Share by Region (2018-2033)
Figure 40. Japan Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Peripheral T-cell lymphoma Therapy Market Share by Country (2018-2033)
Figure 50. Brazil Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Antengene Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2018-2023)
Figure 57. Genor BioPharma Co., Ltd. Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2018-2023)
Figure 58. Hospira (Pfizer Inc.) Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2018-2023)
Figure 59. Dizal Pharma Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2018-2023)
Figure 60. Bristol-Myers Squibb Company Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2018-2023)
Figure 61. Sigma-Tau Pharmaceuticals, Inc. Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2018-2023)
Figure 62. Pacira Pharmaceuticals, Inc. Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2018-2023)
Figure 63. Spectrum Pharmaceuticals, Inc. Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2018-2023)
Figure 64. Celgene Corporation Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2018-2023)
Figure 65. Eisai Co., Ltd. Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2018-2023)
Figure 66. Leadiant Biosciences Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2018-2023)
Figure 67. Merck Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2018-2023)
Figure 68. Genmab AS Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2018-2023)
Figure 69. HUYABIO International Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed